Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Drug overdose
Drug-related harms
Naloxone
Opioids
People who inject drugs
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
11 02 2022
11 02 2022
Historique:
received:
19
03
2021
accepted:
28
10
2021
entrez:
12
2
2022
pubmed:
13
2
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Drug overdoses occur when the amount of drug or combination of drugs consumed is toxic and negatively affects physiological functioning. Opioid overdoses are responsible for the majority of overdose deaths worldwide. Naloxone is a safe, fast-acting opioid antagonist that can reverse an opioid overdose, and as such, it should be a critical component of community-based responses to opioid overdose. However, the burden of drug overdose deaths remains unquantified in South Africa, and both knowledge about and access to naloxone is generally poor. The objective of this study was to describe the experiences of overdose, knowledge of responses to overdose events, and willingness to call emergency medical services in response to overdose among people who use drugs in Cape Town, Durban, and Pretoria (South Africa). We used convenience sampling to select people who use drugs accessing harm reduction services for this cross-sectional survey from March to July 2019. Participants completed an interviewer-administered survey, assessing selected socio-demographic characteristics, experiences of overdose among respondents and their peers, knowledge about naloxone and comfort in different overdose responses. Data, collected on paper-based tools, were analysed using descriptive statistics and categorised by city. Sixty-six participants participated in the study. The median age was 31, and most (77%) of the respondents were male. Forty-one per cent of the respondents were homeless. Heroin was the most commonly used drug (79%), and 82% of participants used drugs daily. Overall, 38% (25/66) reported overdosing in the past year. Most (76%, 50/66) knew at least one person who had ever experienced an overdose, and a total of 106 overdose events in peers were reported. Most participants (64%, 42/66) had not heard of naloxone, but once described to them, 73% (48/66) felt comfortable to carry it. More than two-thirds (68%, 45/66) felt they would phone for medical assistance if they witnessed an overdose. Drug overdose was common among participants in these cities. Without interventions, high overdose-related morbidity and mortality is likely to occur in these contexts. Increased awareness of actions to undertake in response to an overdose (calling for medical assistance, using naloxone) and access to naloxone are urgently required in these cities. Additional data are needed to better understand the nature of overdose in South Africa to inform policy and responses.
Sections du résumé
BACKGROUND
Drug overdoses occur when the amount of drug or combination of drugs consumed is toxic and negatively affects physiological functioning. Opioid overdoses are responsible for the majority of overdose deaths worldwide. Naloxone is a safe, fast-acting opioid antagonist that can reverse an opioid overdose, and as such, it should be a critical component of community-based responses to opioid overdose. However, the burden of drug overdose deaths remains unquantified in South Africa, and both knowledge about and access to naloxone is generally poor. The objective of this study was to describe the experiences of overdose, knowledge of responses to overdose events, and willingness to call emergency medical services in response to overdose among people who use drugs in Cape Town, Durban, and Pretoria (South Africa).
METHODS
We used convenience sampling to select people who use drugs accessing harm reduction services for this cross-sectional survey from March to July 2019. Participants completed an interviewer-administered survey, assessing selected socio-demographic characteristics, experiences of overdose among respondents and their peers, knowledge about naloxone and comfort in different overdose responses. Data, collected on paper-based tools, were analysed using descriptive statistics and categorised by city.
RESULTS
Sixty-six participants participated in the study. The median age was 31, and most (77%) of the respondents were male. Forty-one per cent of the respondents were homeless. Heroin was the most commonly used drug (79%), and 82% of participants used drugs daily. Overall, 38% (25/66) reported overdosing in the past year. Most (76%, 50/66) knew at least one person who had ever experienced an overdose, and a total of 106 overdose events in peers were reported. Most participants (64%, 42/66) had not heard of naloxone, but once described to them, 73% (48/66) felt comfortable to carry it. More than two-thirds (68%, 45/66) felt they would phone for medical assistance if they witnessed an overdose.
CONCLUSION
Drug overdose was common among participants in these cities. Without interventions, high overdose-related morbidity and mortality is likely to occur in these contexts. Increased awareness of actions to undertake in response to an overdose (calling for medical assistance, using naloxone) and access to naloxone are urgently required in these cities. Additional data are needed to better understand the nature of overdose in South Africa to inform policy and responses.
Identifiants
pubmed: 35148779
doi: 10.1186/s12954-021-00561-w
pii: 10.1186/s12954-021-00561-w
pmc: PMC8832761
doi:
Substances chimiques
Analgesics, Opioid
0
Narcotic Antagonists
0
Naloxone
36B82AMQ7N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17Informations de copyright
© 2022. The Author(s).
Références
Int J Drug Policy. 2016 Apr;30:107-15
pubmed: 26860326
J Urban Health. 2013 Dec;90(6):1102-11
pubmed: 23900788
Int J Drug Policy. 2017 Aug;46:54-60
pubmed: 28609749
Addiction. 2014 Feb;109(2):250-9
pubmed: 24103087
Syst Rev. 2019 Jun 11;8(1):138
pubmed: 31186071
S Afr Med J. 2016 May 08;106(6):
pubmed: 27245720
JAMA Netw Open. 2019 Apr 5;2(4):e192613
pubmed: 31002325
J Law Med Ethics. 2013 Mar;41 Suppl 1:33-6
pubmed: 23590737
Inj Epidemiol. 2015 Dec;2(1):10
pubmed: 27747742
Int J Drug Policy. 2017 Dec;50:82-89
pubmed: 29040841
Subst Use Misuse. 2008;43(7):858-70
pubmed: 18570021
CNS Drugs. 2019 Oct;33(10):943-955
pubmed: 31578704
Bull World Health Organ. 2013 Feb 1;91(2):102-23
pubmed: 23554523
J Addict Med. 2020 Jul/Aug;14(4):e118-e132
pubmed: 32011406
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Harm Reduct J. 2019 Apr 11;16(1):28
pubmed: 30975139
Harm Reduct J. 2020 Jan 9;17(1):4
pubmed: 31918740
J Urban Health. 2003 Jun;80(2):261-73
pubmed: 12791802
J Addict Dis. 2006;25(3):89-96
pubmed: 16956873
Int J Drug Policy. 2019 Nov;73:172-184
pubmed: 31351755
Drug Alcohol Depend. 2015 Mar 1;148:209-12
pubmed: 25595053
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207
pubmed: 29074409
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174
Harm Reduct J. 2020 Apr 15;17(1):25
pubmed: 32295595
Int J Drug Policy. 2020 Sep;83:102839
pubmed: 32650228
Lancet. 2019 Oct 26;394(10208):1560-1579
pubmed: 31657732
Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):39-47
pubmed: 29888409